Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 14/20 | 0.58 |
| ▸ | HTT | P42858 | 3/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | CCR6 | P51684 | 1/20 | 0.58 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.58 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrazole SCHEMBL9491091 | 0.83 | ALDH1A1 (0.44) | ALDH1A1HTTHPGDMAPTCCR6 | |
| SCHEMBL4895319 | 0.83 | MAPT (0.59) | ALDH1A1HTTHPGDMAPTLMNA | |
| SCHEMBL8351588 | 0.81 | ALDH1A1 (0.47) | ALDH1A1HTTHPGDMAPTCCR6 | |
| SCHEMBL8351721 | 0.79 | ALDH1A1 (0.57) | ALDH1A1HTTHPGDMAPTCACNA1B | |
| SCHEMBL10373263 | 0.79 | ALDH1A1 (0.61) | ALDH1A1HTTHPGDMAPTCACNA1B | |
| SCHEMBL8499718 | 0.79 | ALDH1A1 (0.47) | ALDH1A1HTTHPGDMAPTCCR6 | |
| SCHEMBL11327422 | 0.79 | ALDH1A1 (0.45) | ALDH1A1HTTHPGDMAPTCCR6 | |
| SCHEMBL3260345 | 0.78 | ALDH1A1 (0.53) | ALDH1A1HTTHPGDMAPTCCR6 | |
| SCHEMBL11536760 | 0.77 | ALDH1A1 (0.65) | ALDH1A1HTTHPGDMAPTCCR6 | |
| SCHEMBL10977161 | 0.75 | ALDH1A1 (0.70) | ALDH1A1HTTHPGDMAPTCCR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 538 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110627736-B | Method for recycling 1-phenyl-5-hydroxy tetrazole | 江苏阿尔法药业有限公司 | 2020-11-06 | — | — | CN | claimed |
| CN-110627736-A | Method for recycling 1-phenyl-5-hydroxy tetrazole | 江苏阿尔法药业有限公司 | 2019-12-31 | — | — | CN | claimed |
| CN-101591304-B | Compound containing tetrazolyl groups and polymers thereof | UNIV SUZHOU | 2011-06-15 | — | — | CN | claimed |
| CN-101591304-A | A kind of compound and polymkeric substance thereof that contains tetrazol group | UNIV SUZHOU (CN) | 2009-12-02 | — | — | CN | claimed |
| US-20090076314-A1 | Bisphenol compound and process for preparation thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2009-03-19 | — | — | US | claimed |
| US-20070073090-A1 | Bisphenol compound and process for preparation thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2007-03-29 | — | — | US | claimed |
| EP-0759922-A1 | NEW ANTAGONIST COMPOUNDS | Astra Aktiebolag (SE) | 1997-03-05 | — | — | EP | claimed |
| WO-1995031463-A1 | NEW ANTAGONIST COMPOUNDS | ASTRA AKTIEBOLAG (SE) | 1995-11-23 | — | — | WO | claimed |
| EP-0304086-B1 | 4'-DESHYDROXYEPIPODOPHYLLOTOXIN GLUCOSIDES AND THEIR USE | Bristol-Myers Squibb Company (US) | 1993-01-20 | — | — | EP | claimed |
| EP-0304086-A2 | 4'-deshydroxyepipodophyllotoxin glucosides and their use | Bristol-Myers Squibb Company (US) | 1989-02-22 | — | — | EP | claimed |
| JP-10204066-A | — | — | None | — | — | JP | disclosed |
| US-12545682-B2 | Heterocyclic derivatives as P2X7 receptor antagonists | BREYE THERAPEUTICS APS (DK) | 2026-02-10 | — | — | US | disclosed |
| EP-4635494-A2 | AMIDO HETEROAROMATIC COMPOUNDS | Astrazeneca AB (SE) | 2025-10-22 | — | — | EP | disclosed |
| EP-4514782-B1 | AMIDO HETEROAROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF LIVER DISEASES | ASTRAZENECA AB (SE) | 2025-09-10 | — | — | EP | disclosed |
| EP-4577204-A1 | MULTIPLE TARGETING OPIOID RECEPTOR LIGANDS AS NOVEL ANALGESICS WITH MINIMUM ABUSE LIABILITY | Virginia Commonwealth University (US) | 2025-07-02 | — | — | EP | disclosed |
| US-4186131-A | CARDIOVASCULAR AGENTS | MEAD JOHNSON & COMPANY (US) | 1980-01-29 | — | — | US | disclosed |
| US-4088658-A | REACTING HYDROXY COMPOUND WITH A SULFONYL CHLORIDE TO FORM SULFONATE, HYDROGENOLYSIS | IMC CHEMICAL GROUP, INC. (US) | 1978-05-09 | — | — | US | disclosed |
| US-4042602-A | Synthesis of dideoxyzearalane and related compounds | IMC CHEMICAL GROUP, INC. (US) | 1977-08-16 | — | — | US | disclosed |
| US-4039543-A | SUBSTITUTED BY AMINE, N-RING, AMIDE, CARBAMATE, UREA | HOFFMANN-LA ROCHE INC. (US) | 1977-08-02 | — | — | US | disclosed |
| US-4012435-A | (5,8-DIHYDRO-5,8-ENDOMETHYLENE-1-NAPHTHYL)- CARBAMATES; PESTICIDES | CIBA-GEIGY AG (CH) | 1977-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545682-B2 | Heterocyclic derivatives as P2X7 receptor antagonists | P2RX7, P2RX3, P2RX1 | ALDH1A1 1416/4885HTT 3447/4885HPGD 2008/4885 |
| US-20090076314-A1 | Bisphenol compound and process for preparation thereof | DOT1L, ACSL3, ASH1L | ALDH1A1 3049/4885HTT 3158/4885HPGD 2115/4885 |
| US-20070073090-A1 | Bisphenol compound and process for preparation thereof | DOT1L, ACSL3, ASH1L | ALDH1A1 3049/4885HTT 3158/4885HPGD 2115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.